SCHEMBL21159362

SCHEMBL21159362

Cn1nc(C2CCCCCC2)c2ncnc(N)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.42
ADORA2A P29274 4/20 0.38
PI4KA P42356 3/20 0.38
PI4K2B Q8TCG2 3/20 0.38
PI4K2A Q9BTU6 3/20 0.38
PI4KB Q9UBF8 3/20 0.38
FFAR2 O15552 4/20 0.37
ADORA3 P0DMS8 3/20 0.36
ADORA1 P30542 3/20 0.36
LIMK1 P53667 1/20 0.36
RET P07949 2/20 0.35
MAP4K4 O95819 1/20 0.35
CHRM4 P08173 1/20 0.34
ADORA2B P29275 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
ADK P55263 1/20 0.34
PDE7A Q13946 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19917018 1.00 EGFR (0.42) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL16074973 0.77 RET (0.50) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL20533284 0.74 EGFR (0.52) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL13593762 0.71 LIMK1 (0.44) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL24499994 0.67 LIMK1 (0.41) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL19917015 0.67 FFAR2 (0.39) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL29012931 0.66 FFAR2 (0.44) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL13019867 0.65 RET (0.57) EGFRLIMK1RETMAP4K4CYP1A2
SCHEMBL25431774 0.65 PDE7A (0.35) ADORA2AADORA2BPDE7A
SCHEMBL23917274 0.63 RET (0.51) EGFRPI4KBLIMK1RETMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3505171-A1 BICYCLIC NITROGENATED HETEROCYCLIC COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2019-07-03 EP disclosed